EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
IDEXX Laboratories, Inc. (IDXX) had EBIT Margin of 33.62% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.11B |
|
$293.99M |
|
$414.73M |
|
$694.73M |
|
$736.41M |
|
$373.05M |
|
$-10.69M |
|
$362.35M |
|
$362.35M |
|
$293.99M |
|
$293.99M |
|
$293.99M |
|
$293.99M |
|
$373.05M |
|
$408.82M |
|
80.41M |
|
80.99M |
|
$3.66 |
|
$3.63 |
|
| Balance Sheet Financials | |
$1.36B |
|
$739.68M |
|
$1.97B |
|
$3.33B |
|
$1.22B |
|
$449.81M |
|
$648.09M |
|
$1.87B |
|
$1.46B |
|
$940.61M |
|
$1.46B |
|
80.15M |
|
| Cash Flow Statement Financials | |
$423.70M |
|
$-63.24M |
|
$-495.95M |
|
$288.27M |
|
$164.59M |
|
$-123.67M |
|
$29.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.11 |
|
-- |
|
-- |
|
0.24 |
|
0.76 |
|
62.62% |
|
33.62% |
|
|
EBIT Margin |
33.62% |
-- |
|
32.66% |
|
26.50% |
|
$359.58M |
|
-- |
|
-- |
|
-- |
|
0.33 |
|
1.06 |
|
1.98 |
|
45.47 |
|
20.15% |
|
31.26% |
|
8.83% |
|
15.40% |
|
$18.20 |
|
$4.44 |
|
$5.23 |
|